Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Efficacy and Safety of Semaglutide Versus Dulaglutide as add-on to Metformin in Subjects With Type 2 Diabetes.

ClinicalTrials.gov ID: NCT02648204

Public ClinicalTrials.gov record NCT02648204. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 24, 2026, 5:15 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Efficacy and Safety of Semaglutide Versus Dulaglutide as add-on to Metformin in Subjects With Type 2 Diabetes

Study identification

NCT ID
NCT02648204
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novo Nordisk A/S
Industry
Enrollment
1,201 participants

Conditions and interventions

Interventions

  • semaglutide Drug
  • Dulaglutide Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 5, 2016
Primary completion
Apr 9, 2017
Completion
May 18, 2017
Last update posted
Oct 14, 2019

2016 – 2017

United States locations

U.S. sites
100
U.S. states
30
U.S. cities
88
Facility City State ZIP Site status
Novo Nordisk Investigational Site Tuscumbia Alabama 35674
Novo Nordisk Investigational Site Chandler Arizona 85224
Novo Nordisk Investigational Site Phoenix Arizona 85032
Novo Nordisk Investigational Site Phoenix Arizona 85050
Novo Nordisk Investigational Site Anaheim California 92801
Novo Nordisk Investigational Site Buena Park California 90620
Novo Nordisk Investigational Site Carlsbad California 92008
Novo Nordisk Investigational Site Concord California 94520
Novo Nordisk Investigational Site Huntington Park California 90255
Novo Nordisk Investigational Site Lincoln California 95648
Novo Nordisk Investigational Site Los Angeles California 90057
Novo Nordisk Investigational Site Montclair California 91763
Novo Nordisk Investigational Site Poway California 92064
Novo Nordisk Investigational Site Riverside California 92506
Novo Nordisk Investigational Site San Diego California 92103
Novo Nordisk Investigational Site Tustin California 92780
Novo Nordisk Investigational Site Van Nuys California 91405
Novo Nordisk Investigational Site Denver Colorado 80220
Novo Nordisk Investigational Site Norwalk Connecticut 06851
Novo Nordisk Investigational Site Clearwater Florida 33756
Novo Nordisk Investigational Site Clearwater Florida 33761
Novo Nordisk Investigational Site Coral Gables Florida 33134
Novo Nordisk Investigational Site Edgewater Florida 32132
Novo Nordisk Investigational Site Fort Lauderdale Florida 33316
Novo Nordisk Investigational Site Kissimmee Florida 34741
Novo Nordisk Investigational Site Miami Florida 33173
Novo Nordisk Investigational Site Orlando Florida 32804
Novo Nordisk Investigational Site Orlando Florida 32806
Novo Nordisk Investigational Site Pembroke Pines Florida 33027
Novo Nordisk Investigational Site Port Orange Florida 32127
Novo Nordisk Investigational Site Tampa Florida 33614
Novo Nordisk Investigational Site Tampa Florida 33634
Novo Nordisk Investigational Site Adairsville Georgia 30103
Novo Nordisk Investigational Site Atlanta Georgia 30342
Novo Nordisk Investigational Site Bainbridge Georgia 39819
Novo Nordisk Investigational Site Conyers Georgia 30094-5965
Novo Nordisk Investigational Site Marietta Georgia 30060
Novo Nordisk Investigational Site Marietta Georgia 30067
Novo Nordisk Investigational Site Suwanee Georgia 30024
Novo Nordisk Investigational Site Meridian Idaho 83646
Novo Nordisk Investigational Site Addison Illinois 60101
Novo Nordisk Investigational Site Chicago Illinois 60607
Novo Nordisk Investigational Site Gillespie Illinois 62033
Novo Nordisk Investigational Site Gurnee Illinois 60031
Novo Nordisk Investigational Site Peoria Illinois 61602
Novo Nordisk Investigational Site Avon Indiana 46123
Novo Nordisk Investigational Site Evansville Indiana 47714
Novo Nordisk Investigational Site Greenfield Indiana 46140
Novo Nordisk Investigational Site Indianapolis Indiana 46254
Novo Nordisk Investigational Site Muncie Indiana 47304
Novo Nordisk Investigational Site Newton Kansas 67114
Novo Nordisk Investigational Site Park City Kansas 67219
Novo Nordisk Investigational Site Covington Kentucky 41011
Novo Nordisk Investigational Site Louisville Kentucky 40213
Novo Nordisk Investigational Site Owensboro Kentucky 42303
Novo Nordisk Investigational Site Hyattsville Maryland 20782
Novo Nordisk Investigational Site Oxon Hill Maryland 20745
Novo Nordisk Investigational Site Methuen Massachusetts 01844
Novo Nordisk Investigational Site Rochester Michigan 48307
Novo Nordisk Investigational Site Port Gibson Mississippi 39150
Novo Nordisk Investigational Site Missoula Montana 59808
Novo Nordisk Investigational Site Trenton New Jersey 08611
Novo Nordisk Investigational Site New York New York 10016
Novo Nordisk Investigational Site Garner North Carolina 27529
Novo Nordisk Investigational Site Whiteville North Carolina 28472
Novo Nordisk Investigational Site Winston-Salem North Carolina 27103
Novo Nordisk Investigational Site Cincinnati Ohio 45242
Novo Nordisk Investigational Site Dayton Ohio 45439
Novo Nordisk Investigational Site Mason Ohio 45040-6815
Novo Nordisk Investigational Site Wadsworth Ohio 44281-9236
Novo Nordisk Investigational Site Tulsa Oklahoma 74136
Novo Nordisk Investigational Site Corvallis Oregon 97330-3737
Novo Nordisk Investigational Site Fleetwood Pennsylvania 19522
Novo Nordisk Investigational Site Harleysville Pennsylvania 19438
Novo Nordisk Investigational Site Philadelphia Pennsylvania 19114
Novo Nordisk Investigational Site Pittsburgh Pennsylvania 15224-2215
Novo Nordisk Investigational Site Pittsburgh Pennsylvania 15236
Novo Nordisk Investigational Site Greer South Carolina 29651
Novo Nordisk Investigational Site Moncks Corner South Carolina 29461
Novo Nordisk Investigational Site Spartanburg South Carolina 29303
Novo Nordisk Investigational Site Rapid City South Dakota 57702
Novo Nordisk Investigational Site Humboldt Tennessee 38343
Novo Nordisk Investigational Site Arlington Texas 76015
Novo Nordisk Investigational Site Corpus Christi Texas 78404
Novo Nordisk Investigational Site Dallas Texas 75230
Novo Nordisk Investigational Site Dallas Texas 75390-9302
Novo Nordisk Investigational Site Houston Texas 77025
Novo Nordisk Investigational Site Houston Texas 77040
Novo Nordisk Investigational Site Houston Texas 77074
Novo Nordisk Investigational Site Houston Texas 77079
Novo Nordisk Investigational Site Houston Texas 77081
Novo Nordisk Investigational Site Houston Texas 77090
Novo Nordisk Investigational Site Katy Texas 77450
Novo Nordisk Investigational Site San Antonio Texas 78231
Novo Nordisk Investigational Site Sugar Land Texas 77479
Novo Nordisk Investigational Site Riverton Utah 84065
Novo Nordisk Investigational Site St. George Utah 84790
Novo Nordisk Investigational Site Spokane Washington 99216-1557
Novo Nordisk Investigational Site Walla Walla Washington 99362-4445
Novo Nordisk Investigational Site Wenatchee Washington 98801-2028

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 109 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02648204, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 14, 2019 · Synced Jul 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02648204 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →